3.445
price up icon5.35%   0.165
 
loading

Finanzdaten der Precigen Inc-Aktie (PGEN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Income/Loss From Continuing Operations Before Tax
449.36%
-146.34
-26.64 -54.15 -19.81 -23.97
Income Tax Expense/Benefit, Deferred
-
- - -0.089 0.012
Income Tax Expense/Benefit
100.00%
-
0.003 - -0.087 0.012
Income/Loss From Continuing Operations After Tax
449.30%
-146.34
-26.64 -54.15 -19.73 -23.98
Net Income/Loss
449.30%
-146.34
-26.64 -54.15 -19.73 -23.98
Preferred Stock Dividends And Other Adjustments
179.00
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.62%
307.17
296.43 293.88 8.4727 275.88
Diluted Average Shares
3.62%
307.17
296.43 293.88 8.4727 275.88
Basic Earnings Per Share
1,078%
-1.06
-0.09 -0.18 -0.06 -0.09
Diluted Earnings Per Share
1,078%
-1.06
-0.09 -0.18 -0.06 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
179.00
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):